Researchers have discovered a gene, Katnal1, integral to the manufacture of healthy sperm. The discovery opens the door to the possibility for a male contraceptive which would interrupt the functioning of that gene, say scientists in a recent report published in PLos Genetics.
Katnal1 plays a crucial role in cell shape, division and mobility, and, in the testes, determines the formation of the sperm head and tail.
"If we can find a way to target this gene in the testes, we could potentially develop a non-hormonal contraceptive," said Dr. Lee Smith in a statement.
"The important thing is that the effects of such a drug would be reversible because Katnal1 only affects sperm cells in the later stages of development, so it would not hinder the early stages of sperm production and the overall ability to produce sperm," he added.
The study may also shed light on why some men are sub-fertile or have improperly functioning sperm.
For comments and feedback contact: editorial@rttnews.com
Health News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.